Uscom Ltd (UCM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Uscom Ltd (UCM) has a cash flow conversion efficiency ratio of 39.661x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.52 Million ≈ $-1.07 Million USD) by net assets (AU$-38.22K ≈ $-27.05K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Uscom Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Uscom Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Uscom Ltd (UCM) financial obligations for a breakdown of total debt and financial obligations.
Uscom Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Uscom Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bounty Oil & Gas NL
AU:BUY
|
-0.011x |
|
Baronsmead Second Venture Trust Plc
LSE:BMD
|
-0.008x |
|
Playfair Mining Ltd.
V:PLY
|
0.001x |
|
Cyanotech Corporation
NASDAQ:CYAN
|
-0.008x |
|
TELES Informationstechnologien AG
XETRA:TLIK
|
N/A |
|
Celtic PLC
LSE:CCP
|
-0.038x |
|
Rainbow Rare Earths Limited
LSE:RBW
|
-0.150x |
|
Bohra Industries Limited
NSE:BOHRAIND
|
0.009x |
Annual Cash Flow Conversion Efficiency for Uscom Ltd (2005–2025)
The table below shows the annual cash flow conversion efficiency of Uscom Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Uscom Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$-38.22K ≈ $-27.05K |
AU$-2.71 Million ≈ $-1.92 Million |
70.897x | +18753.99% |
| 2024-06-30 | AU$3.06 Million ≈ $2.17 Million |
AU$-1.16 Million ≈ $-823.17K |
-0.380x | +18.76% |
| 2023-06-30 | AU$3.04 Million ≈ $2.15 Million |
AU$-1.42 Million ≈ $-1.01 Million |
-0.468x | -186.98% |
| 2022-06-30 | AU$5.94 Million ≈ $4.20 Million |
AU$-967.51K ≈ $-684.58K |
-0.163x | -1012.52% |
| 2021-06-30 | AU$3.08 Million ≈ $2.18 Million |
AU$54.98K ≈ $38.90K |
0.018x | +121.59% |
| 2020-06-30 | AU$3.42 Million ≈ $2.42 Million |
AU$-283.23K ≈ $-200.40K |
-0.083x | +76.33% |
| 2019-06-30 | AU$3.49 Million ≈ $2.47 Million |
AU$-1.22 Million ≈ $-862.86K |
-0.350x | +0.16% |
| 2018-06-30 | AU$4.84 Million ≈ $3.43 Million |
AU$-1.70 Million ≈ $-1.20 Million |
-0.350x | -38.97% |
| 2017-06-30 | AU$3.78 Million ≈ $2.67 Million |
AU$-952.04K ≈ $-673.63K |
-0.252x | +3.60% |
| 2016-06-30 | AU$4.94 Million ≈ $3.49 Million |
AU$-1.29 Million ≈ $-913.32K |
-0.261x | +39.74% |
| 2015-06-30 | AU$2.29 Million ≈ $1.62 Million |
AU$-992.80K ≈ $-702.47K |
-0.434x | -16.52% |
| 2014-06-30 | AU$3.32 Million ≈ $2.35 Million |
AU$-1.24 Million ≈ $-874.36K |
-0.372x | +9.78% |
| 2013-06-30 | AU$2.35 Million ≈ $1.67 Million |
AU$-971.58K ≈ $-687.45K |
-0.413x | +63.38% |
| 2012-06-30 | AU$1.47 Million ≈ $1.04 Million |
AU$-1.66 Million ≈ $-1.17 Million |
-1.127x | -60.99% |
| 2011-06-30 | AU$3.14 Million ≈ $2.22 Million |
AU$-2.19 Million ≈ $-1.55 Million |
-0.700x | -14.47% |
| 2010-06-30 | AU$2.45 Million ≈ $1.73 Million |
AU$-1.50 Million ≈ $-1.06 Million |
-0.611x | -83.86% |
| 2009-06-30 | AU$3.06 Million ≈ $2.16 Million |
AU$-1.02 Million ≈ $-719.05K |
-0.333x | +32.24% |
| 2008-06-30 | AU$3.41 Million ≈ $2.41 Million |
AU$-1.67 Million ≈ $-1.18 Million |
-0.491x | +17.42% |
| 2007-06-30 | AU$5.50 Million ≈ $3.89 Million |
AU$-3.27 Million ≈ $-2.31 Million |
-0.594x | -58.62% |
| 2006-06-30 | AU$8.51 Million ≈ $6.02 Million |
AU$-3.19 Million ≈ $-2.26 Million |
-0.375x | -70.02% |
| 2005-06-30 | AU$11.75 Million ≈ $8.31 Million |
AU$-2.59 Million ≈ $-1.83 Million |
-0.220x | -- |
About Uscom Ltd
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure w… Read more